Why AtaiBeckley Stock Soared Today
Shares of AtaiBeckley (NASDAQ: ATAI) surged on Thursday after the mental health-focused biotechnology company agreed to be acquired by pharmaceutical giant Eli Lilly (NYSE: LLY).
Image source: Getty Images.
Under the terms of the deal, Lilly will purchase AtaiBeckley for $6.75 per share in cash. The healthcare leader will also pay up to $2.50 per share in additional milestone payments if certain development and regulatory goals are achieved.
Source Fool.com
